Jennifer R. Allen

Discovery of a Covalent Inhibitor of KRAS^G12C (AMG 510) for the Treatment of Solid Tumors

Brian A. Lanman, Jennifer R. Allen, John G. Allen et al. · Journal of Medicinal Chemistry · 2019 · 722 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +16

From the Laboratory to the Clinic: A Retrospective on Fully Synthetic Carbohydrate-Based Anticancer Vaccines

Samuel J. Danishefsky, Jennifer R. Allen · Angewandte Chemie International Edition · 2000 · 509 citations

Life Sciences, Immunology, Oncology +17

Preparation and Evaluation of Unimolecular Pentavalent and Hexavalent Antigenic Constructs Targeting Prostate and Breast Cancer:  A Synthetic Route to Anticancer Vaccine Candidates

Govind Ragupathi, Fusataka Koide, Philip O. Livingston et al. · Journal of the American Chemical Society · 2006 · 150 citations

Medicine, Immunology, Oncology +17

Molecular Mechanism of Hepcidin-Mediated Ferroportin Internalization Requires Ferroportin Lysines, Not Tyrosines or JAK-STAT

Sandra L. Ross, Lynn Tran, Aaron Winters et al. · Cell Metabolism · 2012 · 141 citations · Full text

Medicine, Biochemistry, Cell Biology +9

Extensively Drug‐Resistant Tuberculosis in California, 1993–2006

Ritu Banerjee, Jennifer R. Allen, Janice Westenhouse et al. · Clinical Infectious Diseases · 2008 · 128 citations · Full text

Public Health, Pharmacology, Clinical Pharmacology +16